Accurate gene prediction is a cornerstone of modern genomics, with direct implications for understanding disease mechanisms and identifying therapeutic targets.
Accurately identifying gene start sites is a fundamental challenge in genomics, with direct implications for understanding gene regulation, variant interpretation, and drug discovery.
Overlapping genes, once considered rare anomalies in bacteria, are now recognized as a widespread genomic feature present in approximately one-third of all microbial genes.
Accurate gene start prediction is fundamental for genome annotation and understanding regulatory mechanisms, yet it remains a challenge due to weak sequence patterns and a historical lack of standardized benchmarks.
Accurate gene prediction is foundational for downstream analyses in genomics, from functional annotation to drug target identification.
This comprehensive review explores cutting-edge advancements in translation initiation site (TIS) recognition, addressing critical challenges in eukaryotic gene annotation and therapeutic development.
This article provides a comprehensive framework for implementing robust quality control (QC) in prokaryotic gene annotation, a critical step for reliable downstream analysis in microbial genomics and drug development.
Accurately predicting leaderless transcription—where genes are transcribed from promoters lacking typical upstream leader sequences—is crucial for precise genome annotation and understanding bacterial pathogenesis.
This article provides a comprehensive guide for researchers and drug development professionals confronting the pervasive challenge of high false positive rates in the genomic analysis of GC-rich regions.
Gene start site discrepancies between annotation tools pose significant challenges in genomic research, potentially impacting downstream analyses in drug development and clinical diagnostics.